2Meghan York,Ashish Agarwal,Michael Ezekowitz. Physicians’ Attitudes and the Use of Oral Anticoagulants: Surveying the Present and Envisioning Future[J] 2003,Journal of Thrombosis and Thrombolysis(1-2):33～37
4Feinberg WM,Blackshear JL,Laupacis A,et al.Prevalence,age distribution,and gender of patients with atrial fibrillation.Analysis and implications[J].Arch Intern Med,1995,155(5):469-473.
5Khairallah F,Ezzedine R,Ganz LI,et al.Epidemiology and determinants of outcome of admissions for atrial fibrillation in the United States from 1996 to 2001[J].Am J Cardiol,2004,94(4):500-504.
6Hirsh J,Fuster V,Ansell J,et al.American Heart Association/American College of Cardiology Foundation guide to warfarin therapy[J].J Am Coll Cardiol,2003,41(9):1633-1652.
7Camm J.Atrial fibrillationan end to the epidemic?[J].Circulation,2005,112(8):iii.
8Olesen JB,Lip GY,Lindhardsen J,et al.Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study[J].Thromb Haemost,2011,106(4):739-749.
9Hart RG,Pearce LA,Aguilar MI.Metaanalysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation[J].Ann Intern Med,2007,146(12):857-867.
